EA can alleviate motor symptoms and up-regulate VGLUT1 in the ipsilateral STN of rats with PD, suggesting that up-regulation of VGLUT1 in STN may be related to the effect of EA on the motor symptoms of Parkinson’s disease through the cortico-STN pathway [80]. This evidence concerns the gene SLC17A7 and Parkinson disease.